Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.82 USD
-0.03 (-1.62%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.81 -0.01 (-0.55%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 181 - 200 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Weekly
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Weekly
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Extends Lock-up Over Two Years on Privateer''s 75M Shares Held
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Weekly
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Market Highlights
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Weekly
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
1Q19 Results Beat Expectations, Supply Constraints Still Remain
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis - Where are we and where are we going?
Provider: Edison Investment Research Limited
Analyst: JACOBS M
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Market Highlights
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
4Q18 Strong Growth; U.S. - Int''l. Investment to Drive Long-Term Growth
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Market Highlights
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Market Highlights
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Weekly
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Cannabis Market Highlights
Provider: Echelon Welath Partners
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.